Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant

This publication has 15 references indexed in Scilit:

• A prophylactic hepatitis B vaccine with a novel adjuvant system
  Vaccine, 2001
• Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines
  Clinical Therapeutics, 2001
• A hepatitis B vaccine formulated with a novel adjuvant system
  Vaccine, 2000
• Over a decade of experience with a yeast recombinant hepatitis B vaccine
  Vaccine, 1999
• Serological Markers and HLA-DQ2 Haplotype Among First-Degree Relatives of Celiac Patients
  Digestive Diseases and Sciences, 1999
• Response to hepatitis B vaccine: multiple HLA genes are involved
  Tissue Antigens, 1998
• Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
  Vaccine, 1998
• Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination
  Tissue Antigens, 1997
• Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus
  Diabetologia, 1993
• Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations
  The American Journal of Medicine, 1989